1. CCLHD Research Repositories

Campbell Tiley

View Statistics Email Alert RSS Feed

Profile

Loading... 2 0 20 0 false
Credit Name
Campbell Tiley
Full Name
Tiley, Campbell
Main Affilation
Central Coast Local Health District
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Subject:  Cancer

Results 1-19 of 19 (Search time: 0.006 seconds).

PreviewIssue DateTitleAuthor(s)
126-Mar-2024How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?Tiong, Ing Soo; Wall, Meaghan; Bajel, Ashish; Kalro, Akash; Fleming, Shaun; Roberts, Andrew W; Thiagarajah, Nisha; Chua, Chong Chyn; Latimer, Maya; Yeung, David; Marlton, Paula; Johnston, Amanda; Enjeti, Anoop; Fong, Chun Yew; Cull, Gavin; Larsen, Stephen; Kennedy, Glen; Schwarer, Anthony; Kipp, David; Ramanathan, Sundra; Verner, Emma; Tiley, Campbell ; Morris, Edward; Hahn, Uwe; Moore, John; Taper, John; Purtill, Duncan; Warburton, Pauline; Stevenson, William; Murphy, Nicholas J ; Tan, Peter; Beligaswatte, Ashanka; Mutsando, Howard; Hertzberg, Mark; Shortt, Jake; Szabo, Ferenc; Dunne, Karin; Wei, Andrew H
27-Dec-2023Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLGLoo, Sun; Roberts, Andrew W; Anstee, Natasha S; Kennedy, Glen A; He, Simon; Schwarer, Anthony P; Enjeti, Anoop K; D'Rozario, James; Marlton, Paula; Bilmon, Ian A; Taper, John; Cull, Gavin; Tiley, Campbell ; Verner, Emma; Hahn, Uwe; Hiwase, Devendra K; Iland, Harry J; Murphy, Nick; Ramanathan, Sundra; Reynolds, John; Ong, Doen Ming; Tiong, Ing Soo; Wall, Meaghan; Murray, Michael; Rawling, Tristan; Leadbetter, Joanna; Rowley, Leesa; Latimer, Maya; Yuen, Sam; Ting, Stephen B; Fong, Chun Yew; Morris, Kirk; Bajel, Ashish; Seymour, John F; Levis, Mark J; Wei, Andrew H
3Oct-2023Occupational exposure to extremely low-frequency magnetic fields and follicular lymphoma risk: a family case-control studyOdutola, Michael K; van Leeuwen, Marina T; Bruinsma, Fiona J; Benke, Geza; Turner, Michelle C; Trotman, Judith; Turner, Jennifer; Seymour, John F; Prince, H Miles; Milliken, Samuel T; Tiley, Campbell ; Hertzberg, Mark; Roncolato, Fernando; Opat, Stephen; Lindeman, Robert; Verner, Emma; Underhill, Craig R; Cardis, Elisabeth; Giles, Graham; Vajdic, Claire M
4Oct-2022Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control studyOdutola, Michael K; van Leeuwen, Marina T; Turner, Jennifer; Bruinsma, Fiona; Seymour, John F; Prince, H Miles; Milliken, Samuel T; Hertzberg, Mark; Trotman, Judith; Opat, Stephen S; Lindeman, Robert; Roncolato, Fernando; Verner, Emma; Harvey, Michael; Tiley, Campbell ; Underhill, Craig R; Benke, Geza; Giles, Graham G; Vajdic, Claire M
5Sep-2020Melphalan exposure and outcome in obese and non-obese adults with myeloma. A study of pharmacokinetics and pharmacodynamicsTiley, Campbell ; Nath, C.E.; Trotman, J.; Nivison-Smith, I.; Gurney, H.; Zeng, L.; Presgrave, P.; Joshua, D.; Kerridge, Ian ; McLachlan, Andrew ; Shaw, P.J.
6Dec-2019A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support personsTiley, Campbell ; Stevenson, W.; Bryant, J.; Watson, R.; Sanson-Fisher, R.; Oldmeadow, C.; Henskens, F.; Brown, C.; Ramanathan, S.; Enjeti, A.; Guest, J.; Tzelepis, F.; Paul, C.; D'Este, C.
7May-2017Idarubicin dose escalation during consolidation therapy for adult Acute Myeloid LeukemiaTiley, Campbell ; Bradstock, K.F.; Link, E.; Di Iulio, J.; Szer, J.; Marlton, P.; Wei, A.H.; Enno, A.; Schwarer, A.; Lewis, I.D.; D'Rozario, J.; Coyle, L.; Cull, G.; Campbell, P.; Leahy, M.F.; Hahn, U.; Cannell, P.; Lowenthal, R.M.; Moore, J.; Cartwright, K.; Cunningham, I.; Taper, J.; Grigg, A.; Roberts, A.W.; Benson, W.; Hertzberg, M.; Deveridge, S.; Rowlings, P.; Mills, A.K.; Gill, Devinder S ; Bardy, P.; Campbell, L.J.; Seymour, J.F.
8Jul-2016High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantationTiley, Campbell ; Nath, C.E.; Trotman, J.; Presgrave, P.; Joshua, D.; Kerridge, Ian ; Kwan, Y.L.; Gurney, H.; McLachlan, Andrew ; Earl, J.W.; Nivison-Smith, I.; Zeng, L.; Shaw, P.J.
9Sep-2015Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trialTiley, Campbell ; Iland, H.J.; Collins, M.; Bradstock, K.F.; Supple, S.G.; Catalano, A.; Hertzberg, M.; Browett, P.; Grigg, A.; Firkin, F.; Campbell, L.J.; Hugman, A.; Reynolds, J.; Di Iulio, J.; Taylor, K.; Filshie, R.; Seldon, M.; Taper, J.; Szer, J.; Moore, J.; Bashford, J.; Seymour, J.F.
10Jun-2015Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studiesTiley, Campbell ; Lynagh, M.C.; Clinton-McHarg, T.; Hall, A.; Sanson-Fisher, R.; Stevenson, W.; Bisquera, A.
11Aug-2012All-Trans-Retinoic Acid, Idarubicin, and IV Arsenic Trioxide as initial therapy in Acute Promyelocytic Leukemia (APML4)Iland, H.J.; Bradstock, K.F.; Supple, S.G.; Catalano, A.; Collins, M.; Hertzberg, M.; Browett, P.; Grigg, A.; Firkin, F.; Hugman, A.; Reynolds, J.; Di Iulio, J.; Tiley, Campbell ; Taylor, K.; Filshie, R.; Seldon, M.; Taper, J.; Szer, J.; Moore, J.; Bashford, J.; Seymour, J.F.
12Jun-2012A Phase II Study of Risk-Adapted Intravenous Melphalan in patients with AL AmyloidosisMollee, P.; Tiley, Campbell ; Cunningham, I.; Moore, J.; Prince, M.; Cannell, P.; Gibbons, S.; Tate, J.; Paul, S.; Mar Fan, H.; Gill, Devinder S 
13May-2010Population Pharmacokinetics of Melphalan in Patients with Multiple Myeloma Undergoing High Dose TherapyNath, C.E.; Shaw, P.J.; Trotman, J.; Zeng, L.; Duffull, S.; Hegarty, G.; McLachlan, Andrew ; Gurney, H.; Kerridge, Ian ; Kwan, Yiu Lam ; Presgrave, P.; Tiley, Campbell ; Joshua, D.; Earl, J.W.
14Feb-2010Enrollment of Patients to Clinical Trials in Haematological Cancer in New South Wales: Current Status, Perceived Barriers and Opportunities for ImprovementMurray, P.; Kerridge, Ian ; Tiley, Campbell ; Catanzariti, A.; Welberry, H.; Lean, C.; Sinclair, S.; Bishop, J.; Bradstock, K.F.
15Apr-2008Consensus Guidelines for 'Rainy Day' Autologous Stem Cell Harvests in New South WalesTrotman, J.; Presgrave, Peter ; Kwan, Yiu Lam ; Tiley, Campbell ; Estell, J.; Watson, A.M.; O'Brian, T.A.; Peters, D.
161991Treatment of acute graft versus host disease with a murine monoclonal antibody to the IL-2 receptorTiley, Campbell ; Powles, R.; Teo, C.P.; Treleaven, J.; Findlay, M.; Hewetson, M.
171991How do allogeneic bone marrow transplants cure leukaemia? The role of graft versus host diseaseTiley, Campbell ; Powles, R.; Treleaven, J.; Millar, J.; Gordon-Smith, E.; Findlay, M.; Teo, C.; Duncombe, A.; Robinson, G.
18Dec-1990Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: double-blind, placebo-controlled trialTiley, Campbell ; Powles, R.; Smith, C.; Milan, S.; Treleaven, J.; Millar, J.; McElwain, T.; Gordon-Smith, E.; Miliken, S.
19Jun-1989Therapy-induced drug resistance in a human leukemia line (LALW-2). A clinically relevant modelTiley, Campbell ; White, L.; Haber, M.; Brian, M.J.; Norris, M.D.; Trickett, A.; Sosula, L.; Stewart, B.W.